Calidi Biotherapeutics Files 8-K Report
Ticker: CLDWW · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials, regulatory
Related Tickers: CLDI
TL;DR
Calidi Biotherapeutics filed an 8-K on Nov 18, 2024, covering Reg FD and financials.
AI Summary
On November 18, 2024, Calidi Biotherapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as First Light Acquisition Group, Inc. until April 6, 2021, is incorporated in Delaware and headquartered in San Diego, CA.
Why It Matters
This 8-K filing provides important updates and disclosures regarding Calidi Biotherapeutics' regulatory compliance and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant new risks.
Key Numbers
- 001-40789 — SEC File Number (Identifies the company's filing with the SEC)
- 86-2967193 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- First Light Acquisition Group, Inc. (company) — Former company name
- November 18, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego, CA (location) — Business address city and state
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 18, 2024.
What was Calidi Biotherapeutics, Inc. formerly known as?
Calidi Biotherapeutics, Inc. was formerly known as First Light Acquisition Group, Inc.
In which state is Calidi Biotherapeutics, Inc. incorporated?
Calidi Biotherapeutics, Inc. is incorporated in Delaware.
What is the business address of Calidi Biotherapeutics, Inc.?
The business address of Calidi Biotherapeutics, Inc. is 4475 Executive Drive, Suite 200, San Diego, CA 92121.
Filing Stats: 586 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-11-18 08:10:35
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001493152-24-046434.txt ( ) — 297KB
- cldi-20241118.xsd (EX-101.SCH) — 4KB
- cldi-20241118_def.xml (EX-101.DEF) — 29KB
- cldi-20241118_lab.xml (EX-101.LAB) — 36KB
- cldi-20241118_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALIDI BIOTHERAPEUTICS, INC. Dated: November 18, 2024 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer